Consultant Psychiatrists as Chief Executive Officers (CEOs): Competencies and Challenges

Background Effective medical leadership is critical to delivering high-quality healthcare, with evidence linking strong leadership to improved patient outcomes. This study explores the insights and experiences of consultant psychiatrists currently working as Chief Executive Officers (CEOs) of mental health organizations within the United Kingdom (UK), examining how their clinical training influenced their leadership capabilities. Methods This study is a qualitative study with brief closed-item descriptors. The study population was consultant psychiatrists in the United Kingdom serving as CEOs of mental health organizations, a census of n = 5, with n = 4 responses to the survey. A questionnaire was designed by the authors for the purpose of this study. The questionnaire consisted of five multiple-choice questions and five open-ended questions. The results were analysed using descriptive statistics and Braun and Clarke's thematic analysis. Results Of the four psychiatrist CEOs who took part in the study, all had over 20 years of psychiatric experience. Their duration of time as CEO varied, with 2/4 serving for one to three years, 1/4 for four to seven years, and 1/4 for over seven years. Of the aspects of psychiatric training most beneficial to the role of CEO, 4/4 felt that patient-centred care and analytical thinking were beneficial, and 3/4 felt that ethical decision-making, crisis management, empathy, and communication skills were beneficial. The participants highlighted clinical leadership and a deep understanding of human behaviour as major advantages of their medical background. However, challenges such as managing staff expectations, balancing clinical and administrative duties, time constraints, and emotional burnout were also reported. Conclusion Consultant psychiatrists possess transferable skills that align well with leadership roles, including CEO positions. Limitations of this study include the small sample size and the risk of identifiability of the consultant psychiatrist CEOs. This study did not require ethical approval as confirmed by the National Health Service (NHS)/Health Research Authority (HRA) decision tool. Participation in the study was voluntary, and responses were anonymised. While not all psychiatrists may aspire to such roles, targeted training and opportunities should be provided to support those interested in pursuing executive leadership in healthcare.